What happened
FSSAI said a reanalyzed sample failed to meet India's biotin standard; Nestlé said its products comply with regulations.
The Food Safety and Standards Authority of India initiated legal action after a reanalysis found a sample of a Nestlé follow-up infant formula below the required biotin level, Reuters reported. The regulator also filed adjudication cases concerning labeling on two other products. Nestlé said its products comply with applicable rules and that the labels in question had previously received expert approval. This Story presents the regulator's finding and the company's response without presuming the outcome of the proceedings.
Source: Reuters · September 18, 2026
Summary based on linked sources. Details may change.
